Endo



Endo starts manufacturing Novavax’s potential COVID-19 vaccine

  • The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the UK
  • Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product
By Reuters ·